Elsevier logo

Publisher: Elsevier

Related content
Volume 2003, Number 352, April 2003

< previous issue | all issues

FIV apres ICSI: fiable ou non?
pp. 8-8(1)
Author: J.-M.M.

Aspartame biologiquement sans reproche
pp. 8-9(2)
Author: J.-M.M.

Depistage biologique de gastrite atrophique
pp. 10-10(1)
Author: J.-M.M.

Mesures urgentes pour la biotech europeenne
pp. 12-12(1)
Author: J.-M.M.

SARS: un Coronavirus formellement implique
pp. 13-13(1)
Author: J.-M.M.

Inhibiteurs de la myostatine et cachexie
pp. 14-14(1)
Authors: Zimmers T.A.; Davies M.V.

Phospholipase D et epidemies aYersinia pestis
pp. 14-15(2)
Authors: Hinnebusch B.J.; Rudolph A.E.

Hepatosiderose metabolique
pp. 15-15(1)
Author: Venat L.

Maladie du charbon et crainte de bioterrorisme
pp. 16-17(2)
Authors: Bossi P.; Bricaire F.

Resistance aux antibiotiques: Aspects techniques
pp. 19-20(2)
Author: Koeck J.-L.

Les pieges de l'antibiogramme
pp. 21-26(6)
Author: Weber M.

Mecanismes et methodes de detection de la resistance de Staphylococcus aureus aux glycopeptides
pp. 31-39(9)
Authors: Montrciol A.; Reverdy M.-E.; Koeck J.-L.

Les nouvelles beta-lactamases a l'aube du troisieme millenaire
pp. 41-55(15)
Authors: Arlet G.; Philippon A.

Les methodes d'etude de la sensibilite de Mycobacterium tuberculosis aux antibiotiques
pp. 65-74(10)
Authors: Gerome P.; Fabre M.; Koeck J.-L.

< previous issue | all issues

Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content

Text size:

A | A | A | A
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages. print icon Print this page